Changes in osteoporosis therapy in postmenopausal women from the RAC-OST-POL Study: a 10-year follow-up

Abstract

This report describes changes in the therapy for osteoporosis in female patients, a populationbased sample from the RAC-OST-POL Study, during a 10-year follow-up (between 2010 and 2020). The percentage of subjects without any therapy decreased over the observation period but the number of patients on antiresorptive therapy did not change and a general progress was thus observed due to increased calcium and/or vitamin D supplementation. Obviously, calcium and vitamin D supplement cannot replace antiresorptive medications with proven anti-fracture efficacy. Consequently, the level of care, provided to patients with postmenopausal osteoporosis did not improve during the 10-year observation period in the analyzed cohort.